LATS1 activators represent a specific class of chemical compounds that play a critical role in the regulation of cellular processes, particularly those related to cell cycle control and tissue growth. LATS1, or Large Tumor Suppressor Kinase 1, is a key component of the Hippo signaling pathway, a conserved pathway with pivotal roles in development, tissue homeostasis, and organ size control. LATS1 is a serine/threonine kinase that acts downstream in the Hippo pathway and is responsible for phosphorylating key transcriptional coactivators, such as YAP (Yes-associated protein) and TAZ (Transcriptional coactivator with PDZ-binding motif). This phosphorylation event blocks YAP and TAZ from entering the nucleus, where they would otherwise promote the transcription of genes involved in cell proliferation and tissue growth.
The chemical class of LATS1 activators is characterized by their ability to interact with and modulate the activity of LATS1 kinase. These compounds can either enhance or inhibit LATS1's kinase activity, which, in turn, affects the phosphorylation status and nuclear localization of YAP and TAZ. By regulating the activity of LATS1, these activators play a critical role in controlling cell proliferation, apoptosis, and organ size during development and tissue maintenance. Understanding the molecular mechanisms underlying LATS1 activation and its role in the Hippo pathway is fundamental for unraveling the complex regulatory networks that govern tissue growth and homeostasis in various physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of ROCK, which can indirectly affect LATS1 activity by modulating the actin cytoskeleton and cellular tension, influential in Hippo pathway signaling. | ||||||
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
Disrupts YAP-TEAD interactions in the Hippo pathway. By inhibiting YAP, it indirectly promotes LATS1-mediated YAP phosphorylation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A BCR-ABL tyrosine kinase inhibitor that also affects Src family kinases. Src inhibition can impact the Hippo pathway and potentially enhance LATS1 activity. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects lysosomal function and modulates autophagy, a process linked with the Hippo pathway, potentially impacting LATS1 activity. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Lowers cholesterol and impacts various cellular signaling pathways, including those related to cell proliferation and survival, potentially influencing Hippo pathway activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
As a GSK-3β inhibitor, it impacts Wnt signaling and other cellular pathways, which may intersect with Hippo pathway regulation and LATS1 activity. | ||||||
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $199.00 $1165.00 | 1 | |
An inhibitor of PDK1, this compound could affect multiple signaling pathways, including those related to the regulation of the Hippo pathway and potentially LATS1 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, leading to increased cAMP levels, and can modulate various signaling pathways, potentially affecting Hippo pathway dynamics and LATS1 activity. | ||||||